New Delhi:
By September, India is likely to have an indigenous Covid-19 vaccine for children. Indian Council of Medical Research (ICMR)’s National Institute of Virology (Pune) Director Priya Abraham has said amid the ongoing phase II and III trials of Covaxin for the 2-18 age group.

“Hopefully, the results (of the trials) are going to be available very soon. The results will be presented to the regulators. So, by September or just after it, we may have Covid-19 vaccines for children,” Abraham said in an interview to India Science, an OTT channel of the science and technology department.

ICMR and Hyderabad-based vaccine manufacturer Bharat Biotech co-developed Covaxin, India’s first indigenous Covid-19 vaccine. Covaxin is one of the three vaccines being administered in India under the national Covid-19 immunisation programme. The other two are Serum Institute of India’s Covishield, and the Russian Sputnik V.

Leave a Reply

Your email address will not be published. Required fields are marked *